drugset / Trial / NCT03511625
The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
Patients will be assigned to receive either Depo Medrol or Acthar treatment. A synovial biopsy, blood draws, synovial fluid aspiration, and physician assessments will be performed before and after initiating treatment.
Timeline
- Start
- 2018-10-02
- Primary completion
- 2020-02-26
- Completion
- 2024-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 80 iu | Subcutaneous |
| Comparator | Methylprednisolone | Other / unclassified | 40 mg | Intramuscular |